Invention Grant
- Patent Title: Anti-TNFα-antibodies and functional fragments thereof
-
Application No.: US16085567Application Date: 2017-03-16
-
Publication No.: US10774140B2Publication Date: 2020-09-15
- Inventor: Tea Gunde , Sebastian Meyer
- Applicant: Numab Therapeutics AG
- Applicant Address: CH Wädenswil
- Assignee: Numab Therapeutics AG
- Current Assignee: Numab Therapeutics AG
- Current Assignee Address: CH Wädenswil
- Agency: Prismatic Law Group, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@5b9e5560
- International Application: PCT/EP2017/056254 WO 20170316
- International Announcement: WO2017/158101 WO 20170921
- Main IPC: C07K16/24
- IPC: C07K16/24 ; C12N15/85 ; A61K39/395 ; A61K39/00 ; A61P37/06 ; A61P1/04 ; A61K38/00
Abstract:
The present invention relates to antibody molecules and functional fragments thereof, capable of binding to tumor necrosis factor alpha (TNFα), to processes for their production, and to their therapeutic uses.
Public/Granted literature
- US20190092850A1 Anti-TNFalpha-Antibodies and Functional Fragments Thereof Public/Granted day:2019-03-28
Information query
